Drug retention of secondary biologics or JAK inhibitors after tocilizumab or abatacept failure as first biologics in patients with rheumatoid arthritis -the ANSWER cohort study-

被引：0
|
作者：
Kosuke Ebina
Toru Hirano
Yuichi Maeda
Wataru Yamamoto
Motomu Hashimoto
Koichi Murata
Tohru Takeuchi
Koji Nagai
Yonsu Son
Hideki Amuro
Akira Onishi
Sadao Jinno
Ryota Hara
Masaki Katayama
Keiichi Yamamoto
Atsushi Kumanogoh
Makoto Hirao
机构：
[1] Osaka University,Department of Musculoskeletal Regenerative Medicine, Graduate School of Medicine
[2] Osaka University,Department of Respiratory Medicine and Clinical Immunology, Graduate School of Medicine
[3] Kurashiki Sweet Hospital,Department of Health Information Management
[4] Kyoto University,Department of Advanced Medicine for Rheumatic diseases, Graduate School of Medicine
[5] Osaka Medical College,Department of Internal Medicine (IV)
[6] Koshokai Aino Hospital,Rheumatology center
[7] Kansai Medical University,First Department of Internal Medicine
[8] Kobe University Graduate School of Medicine,Department of Rheumatology and Clinical Immunology
[9] Nara Medical University,The Center for Rheumatic Diseases
[10] Osaka Red Cross Hospital,Department of Rheumatology
[11] Wakayama Medical University Hospital,Department of Medical Informatics
[12] Osaka University,Department of Orthopaedic Surgery, Graduate School of Medicine
来源：
Clinical Rheumatology | 2020年 / 39卷
关键词：
Abatacept; Biologics; Drug retention; Janus kinase inhibitors; Rheumatoid arthritis; Tocilizumab;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
页码：2563 / 2572
页数：9
相关论文
共 50 条
  • [1] Drug retention of secondary biologics or JAK inhibitors after tocilizumab or abatacept failure as first biologics in patients with rheumatoid arthritis -the ANSWER cohort study
    Ebina, Kosuke
    Hirano, Toru
    Maeda, Yuichi
    Yamamoto, Wataru
    Hashimoto, Motomu
    Murata, Koichi
    Takeuchi, Tohru
    Nagai, Koji
    Son, Yonsu
    Amuro, Hideki
    Onishi, Akira
    Jinno, Sadao
    Hara, Ryota
    Katayama, Masaki
    Yamamoto, Keiichi
    Kumanogoh, Atsushi
    Hirao, Makoto
    CLINICAL RHEUMATOLOGY, 2020, 39 (09) : 2563 - 2572
  • [2] DRUG RETENTION AND REASONS FOR DISCONTINUATION OF BIOLOGICS AND JAK INHIBITORS IN PATIENTS WITH RHEUMATOID ARTHRITIS - THE ANSWER COHORT STUDY
    Ebina, K.
    Etani, Y.
    Maeda, Y.
    Okita, Y.
    Hirao, M.
    Yamamoto, W.
    Hashimoto, M.
    Murata, K.
    Hara, R.
    Nagai, K.
    Hiramatsu, Y.
    Son, Y.
    Amuro, H.
    Fujii, T.
    Okano, T.
    Ueda, Y.
    Katayama, M.
    Okano, T.
    Kumanogoh, A.
    Okada, S.
    Nakata, K.
    ANNALS OF THE RHEUMATIC DISEASES, 2023, 82 : 234 - 235
  • [3] Drug retention and discontinuation reasons between seven biologics in patients with rheumatoid arthritis -The ANSWER cohort study-
    Ebina, Kosuke
    Hashimoto, Motomu
    Yamamoto, Wataru
    Ohnishi, Akira
    Kabata, Daijiro
    Hirano, Toru
    Hara, Ryota
    Katayame, Masaki
    Yoshida, Shuzo
    Nagai, Koji
    Son, Yonsu
    Amuro, Hideki
    Akashi, Kengo
    Fujimura, Takanori
    Hirao, Makoto
    Yamamoto, Keiichi
    Shintani, Ayumi
    Kumanogoh, Atsushi
    Yoshikawa, Hideki
    PLOS ONE, 2018, 13 (03):
  • [4] Drug retention of biologics and Janus kinase inhibitors in patients with rheumatoid arthritis: the ANSWER cohort study
    Ebina, Kosuke
    Etani, Yuki
    Maeda, Yuichi
    Okita, Yasutaka
    Hirao, Makoto
    Yamamoto, Wataru
    Hashimoto, Motomu
    Murata, Koichi
    Hara, Ryota
    Nagai, Koji
    Hiramatsu, Yuri
    Son, Yonsu
    Amuro, Hideki
    Fujii, Takayuki
    Okano, Takaichi
    Ueda, Yo
    Katayama, Masaki
    Okano, Tadashi
    Tachibana, Shotaro
    Hayashi, Shinya
    Kumanogoh, Atsushi
    Okada, Seiji
    Nakata, Ken
    RMD OPEN, 2023, 9 (03):
  • [5] DRUG RETENTION OF BIOLOGICS OR JAK INHIBITORS IN PATIENTS WITH DIFFICULT-TO-TREAT RHEUMATOID ARTHRITIS: RESULTS FROM THE ANSWER COHORT
    Watanabe, R.
    Okano, T.
    Yamada, S.
    Yamamoto, W.
    Murata, K.
    Murakami, K.
    Ebina, K.
    Maeda, Y.
    Jinno, S.
    Shirasugi, I.
    Son, Y.
    Amuro, H.
    Katayama, M.
    Hara, R.
    Hata, K.
    Yoshikawa, A.
    Hashimoto, M.
    ANNALS OF THE RHEUMATIC DISEASES, 2022, 81 : 527 - 528
  • [6] IMPACT OF SEROPOSITIVITY ON DRUG RETENTION OF BIOLOGICS AND JAK INHIBITORS -THE ANSWER COHORT STUDY
    Etani, Y.
    Ebina, K.
    Okita, Y.
    Maeda, Y.
    Tsujimoto, K.
    Onishi, A.
    Onizawa, H.
    Okano, T.
    Nishimura, K.
    Yoshikawa, A.
    Shiba, H.
    Amuro, H.
    Son, Y.
    Hashimoto, M.
    Okano, T.
    Hara, R.
    Yamamoto, W.
    Kumanogoh, A.
    Okada, S.
    ANNALS OF THE RHEUMATIC DISEASES, 2023, 82 : 1389 - 1389
  • [7] Drug retention of 7 biologics and tofacitinib in biologics-naive and biologics-switched patients with rheumatoid arthritis: the ANSWER cohort study
    Ebina, Kosuke
    Hirano, Toru
    Maeda, Yuichi
    Yamamoto, Wataru
    Hashimoto, Motomu
    Murata, Koichi
    Takeuchi, Tohru
    Shiba, Hideyuki
    Son, Yonsu
    Amuro, Hideki
    Onishi, Akira
    Akashi, Kengo
    Hara, Ryota
    Katayama, Masaki
    Yamamoto, Keiichi
    Kumanogoh, Atsushi
    Hirao, Makoto
    ARTHRITIS RESEARCH & THERAPY, 2020, 22 (01)
  • [8] DRUG RETENTION OF 7 BIOLOGICS AND TOFACITINIB IN BIOLOGICS-NAIVE AND BIOLOGICS-SWITCHED PATIENTS WITH RHEUMATOID ARTHRITIS-THE ANSWER COHORT STUDY
    Ebina, K.
    Hirano, T.
    Maeda, Y.
    Yamamoto, W.
    Hashimoto, M.
    Murata, K.
    Takeuchi, T.
    Shiba, H.
    Son, Y.
    Amuro, H.
    Onishi, A.
    Akashi, K.
    Hara, R.
    Katayama, M.
    Yamamoto, K.
    Kumanogoh, A.
    Hirao, M.
    ANNALS OF THE RHEUMATIC DISEASES, 2020, 79 : 18 - 19
  • [9] Drug retention of 7 biologics and tofacitinib in biologics-naïve and biologics-switched patients with rheumatoid arthritis: the ANSWER cohort study
    Kosuke Ebina
    Toru Hirano
    Yuichi Maeda
    Wataru Yamamoto
    Motomu Hashimoto
    Koichi Murata
    Tohru Takeuchi
    Hideyuki Shiba
    Yonsu Son
    Hideki Amuro
    Akira Onishi
    Kengo Akashi
    Ryota Hara
    Masaki Katayama
    Keiichi Yamamoto
    Atsushi Kumanogoh
    Makoto Hirao
    Arthritis Research & Therapy, 22
  • [10] Drug tolerability and reasons for discontinuation of seven biologics in elderly patients with rheumatoid arthritis-The ANSWER cohort study-
    Ebina, Kosuke
    Hashimoto, Motomu
    Yamamoto, Wataru
    Hirano, Toru
    Hara, Ryota
    Katayama, Masaki
    Onishi, Akira
    Nagai, Koji
    Son, Yonsu
    Amuro, Hideki
    Yamamoto, Keiichi
    Maeda, Yuichi
    Murata, Koichi
    Jinno, Sadao
    Takeuchi, Tohru
    Hirao, Makoto
    Kumanogoh, Atsushi
    Yoshikawa, Hideki
    PLOS ONE, 2019, 14 (05):
12345